{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:44:57Z","timestamp":1790675097774,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.mayocpiqo.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T22:23:51Z","timestamp":1605911031000},"page":"210-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-3789","authenticated-orcid":false,"given":"Indranee","family":"Rajapreyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6349-4704","authenticated-orcid":false,"given":"Jose","family":"Tallaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salpy V.","family":"Pamboukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8305-7410","authenticated-orcid":false,"given":"Ayman Haj","family":"Assad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Lenneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-2192","authenticated-orcid":false,"given":"Silvio","family":"Litovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arka","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Hoopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lenneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.09.004_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3324\/haematol.2012.073031","article-title":"Pulmonary hypertension in POEMS syndrome","volume":"98","author":"Li","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.09.004_bib2","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.09.004_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11606-006-0052-9","article-title":"Pulmonary hypertension and amyloidosis\u2014an uncommon association: a case report and review of the literature","volume":"22","author":"Eder","year":"2007","journal-title":"J\u00a0Gen Intern Med"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2020.09.004_bib4","first-page":"15391","article-title":"Pulmonary arterial hypertension due to pulmonary vascular amyloid deposition in a patient with multiple myeloma","volume":"8","author":"Hashimoto","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.09.004_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1086\/682430","article-title":"Pulmonary hypertension complicating multiple myeloma","volume":"5","author":"Krishnan","year":"2015","journal-title":"Pulm Circ"},{"issue":"11","key":"10.1016\/j.mayocpiqo.2020.09.004_bib6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2169\/internalmedicine.53.1672","article-title":"Successful bortezomib\/dexamethasone induction therapy with lenalidomide in an elderly patient with primary plasma cell leukemia complicated by renal failure and pulmonary hypertension","volume":"53","author":"Tamura","year":"2014","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2020.09.004_bib7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1378\/chest.120.5.1735","article-title":"Pulmonary hypertension in patients with amyloidosis","volume":"120","author":"Dingli","year":"2001","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.09.004_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/679726","article-title":"Severe reversible pulmonary hypertension in smoldering multiple myeloma: two cases and review of the literature","volume":"5","author":"Feyereisn","year":"2015","journal-title":"Pulm Circ"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.09.004_bib9","doi-asserted-by":"crossref","first-page":"1602313","DOI":"10.1183\/13993003.02313-2016","article-title":"Clinical relevance of pulmonary amyloidosis: an analysis of 76 autopsy-derived cases","volume":"49","author":"Ussavarungsi","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.09.004_bib10","first-page":"105","article-title":"Primary amyloidosis, with report of six cases","volume":"25","author":"Dahlin","year":"1949","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2020.09.004_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"9727","key":"10.1016\/j.mayocpiqo.2020.09.004_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.09.004_bib13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.09.004_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjh.13805","article-title":"Recent advances in the management of AL amyloidosis","volume":"172","author":"Kastritis","year":"2016","journal-title":"Br J Haematol"},{"issue":"23","key":"10.1016\/j.mayocpiqo.2020.09.004_bib15","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood-2016-09-692954","article-title":"MGUS to myeloma: a mysterious gammopathy of underexplored significance","volume":"128","author":"Dhodapkar","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2020.09.004_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41408-018-0080-9","article-title":"Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018","volume":"8","author":"Gertz","year":"2018","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.09.004_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","article-title":"Light chain (AL) amyloidosis: the journey to diagnosis","volume":"11","author":"McCausland","year":"2018","journal-title":"Patient"},{"issue":"14","key":"10.1016\/j.mayocpiqo.2020.09.004_bib18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2020.09.004_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24756","article-title":"Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease","volume":"92","author":"Mohan","year":"2017","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2020.09.004_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2007-08-108357","article-title":"Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma","volume":"111","author":"Dispenzieri","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2020.09.004_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality & Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820301879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454820301879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T22:35:53Z","timestamp":1726698953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454820301879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2542454820301879"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.09.004","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}